Fig. 1 · Structure
Documents & Downloads
Pivalopril
Angiotensin-converting Enzyme (ACE) Inhibitor
Pivalopril is a potent angiotensin-converting enzyme (ACE) inhibitor that exhibits significant cardiovascular effects. It is primarily utilized in the management of hypertension and heart failure, facilitating reduced blood pressure and improved cardiac function. Pivalopril's mechanism of action involves the inhibition of ACE, thereby diminishing the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased fluid retention. This compound serves as a valuable tool in cardiovascular research and pharmacological studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 81045-50-3 |
| Applications | Angiotensin-converting Enzyme (ACE) Inhibitor |
| Formula | C16H27NO4S |
| Molecular Weight | 329.45 |
| Synonyms | Pivopril; RHC 3659(S) |
| SMILES | O=C(O)CN(C1CCCC1)C([C@H](C)CSC(C(C)(C)C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.